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80th (Autumn) Meeting of Ulster Society of 
Internal Medicine, Friday 17th October 2008
Sir Samuel Irwin Lecture Theatre,  
Royal Victoria Hospital, Belfast.
PROGRAMME:
Chairman:  Dr Kate Ritchie
2.00pm  Papers 
3.00pm  Invited Abstract:  ‘Update on Management of type 2 Diabetes’. 
Prof. Patrick Bell, Royal Victoria Hospital.
3.30pm  Afternoon Tea
3.50pm  Papers
4.30pm  Presentation of prize for best abstract
4:50pm  Guest  lecture:    ‘Occupational  lung  disease  in  the  21st 
century’. Dr Chris Stenton, Consultant Respiratory Physician, 
Newcastle-Upon-Tyne.
PAPERS
EPithEliAl tO MESEnchyMAl tRAnSitiOn in Skin – 
POSSiblE iMPlicAtiOnS fOR SclEROdERMA
D O’Kane1, S Kenny1, J Tolland2, AE Smyth3, JS Elborn1, DF McAuley1, 
CM O’Kane1.
1Respiratory  Medicine  Research  Group,  Queen’s  University  Belfast, 
2Department of Dermatology, Ulster Hospital Dundonald, 3Department of 
Rheumatology, Ulster Hospital Dundonald
Fibrogenic growth factors can force epithelial cells of the lung, kidney and 
liver to undergo transition to a mesenchymal phenotype – a process known 
as epithelial to mesenchymal transition (EMT)1. EMT contributes to fibrosis 
in these organs, and can be inhibited/reversed in animal models2 . EMT has 
not been shown in fibrotic skin disorders.  We hypothesised that EMT is a 
mechanism of dermal fibrosis and may mediate fibrosis in scleroderma and 
other skin lesions.
Human keratinocytes (HaCaT cells) were stimulated with TGFβ and TNFα 
(which occur in fibrotic skin). Cells lysates were probed by western blot for 
epithelial (E-cadherin) and mesenchymal (vimentin) markers. Supernatants 
were analysed for matrix metalloproteinases (MMP-2/-9), enzymes associated 
with  the  invasive,  motile  phenotype  integral  to  EMT  and  CXCL8,  a 
chemokine secreted in high quantities by activated fibroblasts.  Keratinocytes 
stimulated with TGFβ and TNFα became spindle-shaped, with loss of cell-
cell contact. There was a switch from epithelial to mesenchymal proteome: 
vimentin expression increased 3.4 fold, E-cadherin fell by 60% (p=0.02*). 
MMP-2 increased from 121+/-44 to 1174+/-86 relative gelatinolytic units 
(RGU), p<0.001*, and MMP-9 from 24 to 805+/-80 RGU, p<0.001*. CXCL8 
increased from 671 to 1562pg/ml, p=0.0005*. (* t test TGFβ +TNFα vs. 
control)    
Keratinocytes  stimulated  with  TGFβ+TNFα  (present  in  cutaneous 
scleroderma)  undergo  changes  consistent  with  EMT.  These  novel  data 
suggest EMT is a possible mechanism of skin fibrosis. Targeting EMT in 
vivo by inhibiting downstream regulators of TGFβ and TNFα signalling may 
be a novel approach to limit progression of dermal fibrosis in scleroderma 
/ other diseases. 
REfEREncES: 
1.   Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell 
AN, et al. Alveolar epithelial cell mesenchymal transition develops in 
vivo during pulmonary fibrosis and is regulated by the extracellular 
matrix. PNAS 2006;103(35):13180-5.  
2.   Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, et 
al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal 
transition and reverses chronic renal injury. Nat Med 2003;9(7):964-8.
thE uSE Of iMPlAntAblE cARdiOvERtER 
dEfibRillAtORS in PAtiEntS with hyPERtROPhic 
cARdiOMyOPAthy; ExPERiEncE Of A tERtiARy 
REfERRAl cEntRE in nORthERn iRElAnd.
M Sharif, V Kodoth, JR Bennett, J McOsker, M Roberts, C Wilson, E Lau, 
G Manoharan, PP McKeown. 
The Heart Centre, Royal Victoria Hospital, Belfast Health and Social Care 
Trust, Belfast
Hypertrophic Cardiomyopathy (HCM) is the most common cause of sudden 
cardiac  death  (SCD)  in  young  people1.  The  implantable  cardioverter-
defibrillator (ICD) has been shown to be a safe and effective therapeutic 
intervention  in  patients  with  HCM,  both  for  primary  and  secondary 
prevention of SCD. We reviewed ICD data of patients with HCM to determine 
the indications for, efficacy, safety and complications of the device.
Out of 828 patients currently being reviewed in ICD clinic, Royal Victoria 
Hospital, Belfast 28 patients (4%) had HCM as primary diagnosis. Twenty 
four  (85%)  ICDs  were  inserted  for  primary  prevention  and  4  (15%) 
for  secondary  prevention  of  SCD.  Pre  ICD  insertion  the  following  risk 
factors for SCD were identified; 13 (46%) had a family history of SCD, 
6 (21%) had a history of syncope, 5 (17%) had nonsustained ventricular 
tachycardia, 4 (14%) had ventricular tachycardia, 4 (14%) had frequent 
ventricular premature complex, 2 (7%) had atrial fibrillation and 2 (7%) had 
supraventricular tachycardia on holter monitor prior ICD insertion, 2 (7%) 
had an inappropriate blood pressure response to exercise and 2 (7%) had a 
raised left ventricular outflow tract velocity. The mean septal diameter was 
22±6mm. The mean age of ICD insertion was 49.6±17years. During a mean 
follow up period of 32months, 9 appropriate shocks were delivered in 6 
patients (21%) and 3 inappropriate shocks were delivered in 3 (10%) patients.   
Four patients who had appropriate shock delivered were on oral amiodarone 
and one patient on sotalol. Complications identified included one patients 
requiring ICD box replacement and one patient required lead replacement 
due to insulation defect of the leads.
The high rate of appropriate ICD shocks in our study is similar to published 
data2. Risk assessment for SCD should be performed in every HCM patient 
and ICD should be considered in high risk patients.
REfEREncES: 
1.   Maron BJ, Spirito P. Implantable Defibrillators and Prevention of Sudden 
Death in Hypertrophic Cardiomyopathy, J Cardiovasc Electrophysiol 
2008 [Epub ahead of print]. 
2.   Maron BJ, Spirito P, Shen WK et al. Implantable cardioverter-defibrillators 
and prevention of sudden cardiac death in hypertrophic cardiomyopathy; 
JAMA 2007;298(4):405-12.© The Ulster Medical Society, 2009.
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biSPhOSPhOnAtE PREScRibinG GuidElinES – iS 
EvERyOnE A lOSER?
MC McCloskey, J Smyth, W Marshall, N Leonard
Renal Unit, Ulster Hospital, Dundonald, Belfast, Northern Ireland
Osteoporotic fractures are 3 to 4 times more likely in persons with chronic 
kidney disease (CKD). Early menopause, previous exposure to steroids and 
increased risk of falls are all contributory factors1,2. National Institute of 
Clinical Excellence (NICE) guidelines on the treatment of osteoporosis do not 
extend to the CKD population3 and current manufacturer guidelines do not 
recommend the use of bisphosphantes (BPs) in those patients with an eGFR 
< 30ml/min4. We aimed to assess compliance with precribing guidelines and 
to determine if BPs are underutilized across the entire spectrum of CKD.
Data was collected from a computerised data base of six-hundred and thirty 
seven patients with CKD currently attending our renal unit. Six point three 
percent (40/637) of the CKD population were prescribed a BP, 50% (20/40) 
of whom had an eGFR < 30ml/min.  Four point four percent (28/637) 
had a documented diagnosis of  osteoporosis (OP) or OP related fracture.   
However, of those with eGFR > 30 ml/min and thus eligible for BP therapy, 
only one third (3/9) were actually prescribed a BP.  Nine point four percent 
(60/637) of the total population were receiving long term steroid therapy but 
only 50% (15/28) of those with eGFR >30 ml/min, and thus eligible, were 
prescribed a BP. 
This  study  demonstrates  non-adherence  to  bisphosphonate  prescribing 
guidelines in persons with an eGFR <30 ml/min. However, and perhaps 
more importantly, we have highlighted an underutilisation of BP therapy 
in  those  with  eGFR  >30  ml/min.    BPs  have  established  efficacy  in  the 
treatment of OP and OP related fracture in the general population.1,2  The 
underutilisation of BPs in CKD observed in this study, endorsed by both 
national and manufacturers’ guidelines, may be explained in part by the 
absence of supportive data in CKD, theorotical concerns of inducing low 
bone turnover states, and previous reports of acute tubular necrosis with 
intravenous preparations.1,2  
This study generates the following questions: Should we be extrapolating 
data from the general population, should we extrapolate the data and adjust 
the dosage, or should we wait for randomised controlled trials on BPs in 
CKD.  As previous authors have suggested, extrapolation of data with dose 
adjustment seems the most practical and safe approach for the short term.
REfEREncES: 
1.  Hamilton DV . Osteoporosis in women undergoing chronic dialysis. Br 
J Renal Med 2007;12(2):19-21. 
2.   Miller PD. Treatment of osteoporosis in chronic kidney disease and 
end-stage renal disease. Curr Osteoporos Rep 2005;2:5-12. 3. National 
Institute for Health and Clinical Excellence. http://www.nice.org.uk/  4. 
British National Formulary. http://www.bnf.org/bnf/
iS hyPERfiltRAtiOn ASSOciAtEd with thE futuRE 
RiSk Of dEvElOPinG diAbEtic nEPhROPAthy? A MEtA-
AnAlySiS
Glynis M Magee1, Rudy Bilous2, Chris R Cardwell3, Steven J Hunter1, Frank 
Kee3, Damian G Fogarty3.
1. Regional Centre for Diabetes and Endocrinology, Royal Victoria Hospital, 
Belfast, UK. 2. Newcastle University and James Cook University Hospital, 
Middlesbrough, England. 3. Department of Epidemiology and Public Health, 
School  of  Medicine  and  Dentistry,  Queen’s  University,  Belfast,  UK.  4. 
Regional Nephrology Unit, Belfast City Hospital, UK.
Aims:  Glomerular  hyperfiltration  is  well  established  as  a  phenomenon 
occurring early in type 1 and type 2 diabetes, however, there is no consistent 
answer  regarding  whether  hyperfiltration  predicts  the  later  development 
of  nephropathy.  We  performed  a  systematic  review  and  meta-analysis 
of  observational  studies  that  compared  the  risk  of  developing  diabetic 
nephropathy in patients with and without glomerular hyperfiltration.
Methods: A systematic review and meta - analysis was carried out. Cohort 
studies in type 1 and 2 diabetic participants were included if they contained 
data on the development of incipient or overt nephropathy with baseline 
measurement of glomerular filtration rate (GFR) and presence or absence 
of hyperfiltration.
Results: Eleven cohort studies following 830 patients were included. After a 
study median follow up of 7.9 years, 124 patients had developed nephropathy. 
Using a random effects model, the pooled odds of progression to a minimum 
of microalbuminuria in individuals with hyperfiltration was 2.54 (95% CI 
1.25-5.17) times that of individuals with normofiltration. There was moderate 
heterogeneity (Heterogeneity test p = 0.07, I2 = 42%) and some evidence of 
funnel plot asymmetry, possibly due to publication bias. The pooled weighted 
mean difference in baseline GFR was 13.4 ml/min/1.73m2 (95% CI 5.4-
21.3) greater in the group progressing to nephropathy compared to those not 
progressing (Heterogeneity test p<0.01).
conclusions: In published studies, individuals with glomerular hyperfiltration 
were at increased risk of progression to diabetic nephropathy using study level 
data. Further larger studies are required to explore this relationship and the 
role of potential confounding variables.
Audit Of SEcOndARy PREvEntiOn Of OStEOPOROSiS 
in POSt-MEnOPAuSAl fEMAlES tREAtEd in A diStRict 
GEnERAl hOSPitAl
I Wallace, PV Gardiner.
Department of Rheumatology, Altnagelvin Area Hospital, Western Health and 
Social Care Trust, Londonderry, UK.
background: Osteoporosis may lead to significant morbidity and disability 
through an increased susceptibility to fracture.  Post-menopausal females are 
a high-risk group accounting for 74% of neck of femur fractures in our unit.   
Appropriate treatment may reduce the risk of re-fracture in this group.  
Aim: To compare current practice to guidelines contained in the National 
Institute for Clinical Excellence (NICE) Technology Appraisal 87.
Methods: A sample group of 100 patients was identified retrospectively using 
emergency department records.  Female patients over 55 years of age with 
diagnosis of a classical osteoporotic fracture were included.  
Results: 62% were aged 75 or greater. 62% sustained a fracture of neck of 
femur, 29% a wrist fracture and 9% a vertebral fracture.  8% underwent a 
DEXA scan.  In the under 75 group 30 patients (of an eligible 38 (79%)) did 
not receive a DEXA scan.  Treatment was consistent with the NICE guidelines 
in 41% of patients. Most (33 (80%)) were aged 75 or over and 8 (20%) were 
aged under 75.  In the under 75 age group, treatment was commenced in 
17 of 38 patients (45%).  In 9 patients (24%) treatment was commenced 
without performing a DEXA scan.  47% of those aged 75 or over and 79% 
of those in the under-75 age group did not receive treatment according to 
NICE guidelines.
conclusions: DEXA scanning is under-utilised, contributing to significant 
inconsistent treatment decisions. Adherence to the NICE guidelines is higher 
in the 75 and over age group, however in a significant proportion treatment 
is sub-optimal.
Chronic kidney disease associated with mortality in Northern Ireland
M Quinn1, C Cardwell2, G Savage2, AP Maxwell1, F Kee2, D Fogarty1
1Department of Nephrology. 2Department of Public Health and Epidemiology. 
The Queen’s University of Belfast
introduction: We sought to investigate if the increased mortality shown to be 
associated with chronic kidney disease (CKD) in the US population1 is also 
present in Northern Ireland (NI). 
Methods: All creatinine results in Northern Ireland between 1st Jan 2001 - 31st 
Dec 2002 were collected. Estimated glomerular filtration rates (eGFR) were 
then calculated using the 4 variable modified diet in renal disease (MDRD) 
equation. A patient level database was created and mortality follow up was 
provided from the Registrar Generals office up to 31st Dec 2006. 
Results: 2,065,694 creatinine results from 585,566 patients were collected. 
Mean (Standard Deviation) duration of follow up was 3.3 (2.2) yrs. During 
survival follow up there were 60,209 deaths. Using eGFR as time varying 
covariate within a Cox proportional hazards model the following association 
between CKD and mortality was demonstrated.© The Ulster Medical Society, 2009.
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Adjusted† hazard ratios (ci 95%) for death from any cause 
 Estimated GFR
    > 60 ml/min/1.73m2
45 - 59 ml/min/1.73m2
30 - 44 ml/min/1.73m2
15 - 29 ml/min/1.73m2  
   < 15 ml/min/1.73m2
Death from any cause





†Adjusted for Age and Sex 
conclusions: This study demonstrates a graded association between CKD 
and mortality in the tested NI population. The risk of death rose sharply when 
an estimated GFR of < 45 ml/min/1.73m2 was recorded. Having previously 
calculated the prevalence of CKD (eGFR < 60 ml/min/1.73m2) in NI as 
3.69%2; this further work clearly indicates the clinical and public health 
importance of CKD.
REfEREncES: 
1.   Go, AS, Chertow GM, Fan D, et al. Chronic kidney disease and the 
risks of death, cardiovascular events, and hospitalization. N Eng J Med 
2000;351:1296-1305. 
2.   Quinn MP, Rainey A, Cairns KJ, et al. The practical implications of using 
standardized estimation equations in calculating the prevalence of chronic 
kidney disease. Nephrol Dialysis Transplant 2000;23(2):542-548.
fAtAl tRAnSMiSSiOn Of tubERculOSiS in An AcutE 
MEdicAl AdMiSSiOn unit (AMAu).
N McNiece, N Chapman, A John, RP Convery
Dept. of Respiratory Medicine, Craigavon Area Hospital.  County Armagh. 
BT63 5QQ
A 33 year old male was admitted from the local Psychiatric unit with apparent 
pneumonia. A chronic schizophrenic and heavy smoker, he had spent some 
15 years in institutional care in various facilities. He was treated with high 
flow humidified oxygen and nebulised bronchodilators. 48 hours later he was 
found to be sputum smear positive for AAFB.
He was isolated and the Infection Control Team mobilised. He turned out to 
have a fully sensitive M.TB organism and responded well to treatment. BTS 
TB guidelines were followed and all staff and patients in the same ward bay 
as the patient were informed and letters sent to all GPs.
One patient contact had oesophageal carcinoma and was a chronic alcoholic. 
He developed post operative pleural effusion (TB culture positive) some 6 
months post exposure. A second contact (also alcoholic) was investigated as 
possible lung cancer some 30 months after exposure and was Smear positive 
for AAFB. Both patients died on treatment for their TB.
All 3 TB isolates were identical. The index case is alive and well. This 
highlights the danger of even short delays in diagnosis and appropriate 
isolation of TB patients. It also highlights the use of RFLP/genotyping in 
case series and evaluation.